| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |